UHCs 2026 commercial PA criteria for Wegovy require five elements: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity
Expect the doctor to ask about menstrual history, hormone use, and family history of gynecologic cancers
You can learn more about the benefits and risks of compounding pharmacies here
If you are part of a program through our platform, you can consult with your assigned provider to determine the safest way to restart
Patients with pancreatitis history or severe gastrointestinal disease should explore alternatives with their provider
(2009) identified that after increasing the quantity of Bifidobacterium in the intestine, the content of proglucagon mRNA was higher, which promoted the secretion of glucagon-derived peptides